In contrast, in Ag+ HCC mice, Akt2-OE CTLs displayed robust proliferation as evidenced by EdU incorporation on days 4 and 7 and significant expansion in tumor tissues from day 4 to day 11 (figure 3D,E, online supplemental figure S7). Here, AKT2 is linked to hepatocellular carcinoma.